Cargando…
Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
Ubiquitin-conjugating enzyme E2 C (UBE2C) plays a carcinogenic role in gastric cancer (GC); yet, its role in cisplatin (DDP) resistance in GC is enigmatic. This study sought to probe into the impact of UBE2C on DDP resistance in GC and its concrete molecular mechanism in GC progression. Bioinformati...
Autores principales: | Long, Jiegen, Zhu, Bin, Tian, Tao, Ren, Linfei, Tao, Yong, Zhu, Haitao, Li, Dengwei, Xu, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571520/ https://www.ncbi.nlm.nih.gov/pubmed/37840753 http://dx.doi.org/10.1515/med-2023-0757 |
Ejemplares similares
-
Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients
por: Jia, Yongxu, et al.
Publicado: (2019) -
PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer
por: He, Qiuming, et al.
Publicado: (2023) -
A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
por: Liu, Qian, et al.
Publicado: (2021) -
Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells
por: Lee, Yuri, et al.
Publicado: (2022) -
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
por: Zhao, Jun-Zhang, et al.
Publicado: (2022)